STIFEL FINANCIAL CORP - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,055,655
+0.5%
1,844,019
-0.0%
0.02%0.0%
Q2 2023$12,985,660
-15.6%
1,844,554
+0.0%
0.02%
-18.2%
Q1 2023$15,379,577
-27.4%
1,844,0740.0%0.02%
-31.2%
Q4 2022$21,169,970
-9.0%
1,844,074
-0.1%
0.03%
-15.8%
Q3 2022$23,261,000
+18.8%
1,846,174
-0.2%
0.04%
+22.6%
Q2 2022$19,573,000
-34.9%
1,850,024
-0.0%
0.03%
-24.4%
Q1 2022$30,086,000
+17.5%
1,850,342
+0.0%
0.04%
+20.6%
Q4 2021$25,616,000
-3.7%
1,849,524
-0.0%
0.03%
-12.8%
Q3 2021$26,590,000
-9.1%
1,850,3540.0%0.04%
-11.4%
Q2 2021$29,254,000
+55.5%
1,850,3540.0%0.04%
+41.9%
Q1 2021$18,818,000
+23.7%
1,850,354
-9.4%
0.03%
+14.8%
Q4 2020$15,213,000
+116.9%
2,042,0990.0%0.03%
+92.9%
Q3 2020$7,015,000
-27.9%
2,042,0990.0%0.01%
-36.4%
Q2 2020$9,730,000
+132.7%
2,042,099
-2.4%
0.02%
+83.3%
Q1 2020$4,182,0002,091,2690.01%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DG Capital Management, LLC 1,186,726$4,076,0002.45%
Sarissa Capital Management LP 4,861,000$16,697,0001.97%
Ghost Tree Capital, LLC 1,950,000$6,698,0001.94%
ORACLE INVESTMENT MANAGEMENT INC 2,525,857$8,676,0001.14%
Eversept Partners, LP 1,143,211$3,926,9300.87%
DAFNA Capital Management LLC 749,051$2,573,0000.84%
KNOTT DAVID M 397,361$1,365,0000.80%
Parkman Healthcare Partners LLC 800,740$2,751,0000.73%
ACUTA CAPITAL PARTNERS, LLC 660,000$2,267,0000.62%
Formidable Asset Management, LLC 578,200$1,949,0000.57%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders